Home > Compound List > Compound details
191217-81-9 molecular structure
click picture or here to close

(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrate dihydrochloride

ChemBase ID: 72839
Molecular Formular: C10H21Cl2N3OS
Molecular Mass: 302.26424
Monoisotopic Mass: 301.07823867
SMILES and InChIs

SMILES:
[C@@H]1(CCc2c(C1)sc(n2)N)NCCC.Cl.Cl.O
Canonical SMILES:
CCCN[C@H]1CCc2c(C1)sc(n2)N.O.Cl.Cl
InChI:
InChI=1S/C10H17N3S.2ClH.H2O/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H;1H2/t7-;;;/m0.../s1
InChIKey:
APVQOOKHDZVJEX-QTPLPEIMSA-N

Cite this record

CBID:72839 http://www.chembase.cn/molecule-72839.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrate dihydrochloride
IUPAC Traditional name
pramipexole hydrate dihydrochloride
Synonyms
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrate dihydrochloride
Mirapex
Mirapexin
Sifrol
Pramipexole dihydrochloride monohy
CAS Number
191217-81-9
MDL Number
MFCD02183927
PubChem SID
162037760
PubChem CID
166589

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
PubChem 166589 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 17.661047  H Acceptors 3 
H Donor 2  LogD (pH = 5.5) -1.5217185 
LogD (pH = 7.4) -0.98125774  Log P 1.7642827 
Molar Refractivity 59.7672 cm3 Polarizability 22.761166 Å3
Polar Surface Area 50.94 Å2 Rotatable Bonds 3 
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Product Information Bioassay(PubChem)
Hydrophobicity(logP)
1.168 expand Show data source
Storage Condition
-20°C expand Show data source
Purity
95% expand Show data source
Salt Data
Coordination Co expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S2011 external link
Research Area: Neurological Disease
Biological Activity:
Pramipexole is a partial/full D2S, D2L, D3, D4, receptor agonist with a Ki of 3.9, 2.2, 0.5, 5.1 nM. It also possesses low/insignificant affinity (500-10,000 nM) for the 5-HT1A, 5-HT1B, 5-HT1D, and α2-adrenergic receptors. It has negligible affinity (>10,000 nM) for the D1, D5, 5-HT2, α1-adrenergic, β-adrenergic, H1, and mACh receptors. It is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson’s disease (PD) and restless legs syndrome (RLS). [1][2][3]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • http://en.wikipedia.org/wiki/Pramipexole
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle